Tolskaya E A, Romanova L I, Kolesnikova M S, Gmyl A P, Gorbalenya A E, Agol V I
Institute of Poliomyelitis and Viral Encephalitides, Russian Academy of Medical Sciences, Moscow Region.
J Mol Biol. 1994 Mar 11;236(5):1310-23. doi: 10.1016/0022-2836(94)90060-4.
Poliovirus RNA replication is known to be inhibited by millimolar concentrations of guanidine. A variety of guanidine-resistant (gr) and guanidine-dependent (gd) poliovirus strains were selected, and mutations responsible for the phenotypic alterations were mapped to distinct loci of the viral NTP-binding pattern containing protein 2C. Together with already published results, our data have demonstrated that the overwhelming majority of guanidine mutants of poliovirus 2C can be assigned to one of the two classes, N (with a change in Asn179) or M (with a change in Met187). As inferred from the structure/function relations in other NTP-binding proteins, both these "main" mutations should reside in a loop adjoining the so-called B motif known to interact with the Mg2+ involved in the NTP splitting. In classes M (always) and N (not infrequently), these B motif mutations were combined with mutations in, or close to, motif A (involved in binding of the NTP phosphate moieties) and/or motif C (another conserved element of a subset of NTP-binding proteins). These data strongly support the notion that the region of polypeptide 2C involved in the NTP utilization is affected by the guanidine mutations and by the presence of the drug itself. The mutations, however, never altered highly conserved amino acid residues assumed to be essential for the NTP binding or splitting. These facts and some other considerations led us to propose that guanidine affects coupling between the NTP binding and/or splitting, on the one hand, and the 2C function (related to conformational changes), on the other. Both N and M classes of mutants contain gr and gd variants, and the gr/gd interconversion as well as modulations of the guanidine phenotype can be caused by additional mutations within each class; sometimes, these additional substitutions are located far away from the "main" mutations. It is suggested that the target for guanidine action involves long-range tertiary interactions. Under conditions restrictive for the individual growth of each parent, efficient reciprocal intra-allelic complementation between guanidine-sensitive (gs) and gd strains (of M or N classes) was observed. The complementation occurred at the level of viral RNA synthesis. These data allowed us to propose that oligomerization of polypeptide 2C is an essential step in the replication of viral genome.
已知毫摩尔浓度的胍会抑制脊髓灰质炎病毒RNA复制。我们筛选了多种对胍耐药(gr)和依赖胍(gd)的脊髓灰质炎病毒株,并将导致表型改变的突变定位到病毒NTP结合模式相关蛋白2C的不同位点。结合已发表的结果,我们的数据表明,脊髓灰质炎病毒2C的绝大多数胍突变体可归为两类之一,即N类(天冬酰胺179位发生改变)或M类(甲硫氨酸187位发生改变)。从其他NTP结合蛋白的结构/功能关系推断,这两个“主要”突变都应位于与已知与参与NTP裂解的Mg2+相互作用的所谓B基序相邻的环中。在M类(总是)和N类(不罕见)中,这些B基序突变与基序A(参与NTP磷酸基团结合)和/或基序C(NTP结合蛋白子集的另另另保守元件)内或附近的突变相结合。这些数据有力地支持了这样一种观点,即参与NTP利用的2C多肽区域受到胍突变和药物本身存在的影响。然而,这些突变从未改变假定对NTP结合或裂解至关重要的高度保守氨基酸残基。这些事实和其他一些考虑因素使我们提出,胍一方面影响NTP结合和/或裂解与另一方面2C功能(与构象变化相关)之间的偶联。N类和M类突变体都包含gr和gd变体,并且gr/gd相互转换以及胍表型的调节可由每类中的额外突变引起;有时,这些额外的替换位于远离“主要”突变的位置。有人提出,胍作用的靶点涉及远距离三级相互作用。在限制每个亲本单独生长的条件下,观察到胍敏感(gs)和gd菌株(M类或N类)之间有效的等位基因内互补。互补发生在病毒RNA合成水平。这些数据使我们能够提出,多肽2C的寡聚化是病毒基因组复制中的一个关键步骤。